Baxter Hlthcare patent expiration
1. Brevibloc patent expiration
BREVIBLOC IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6310094 | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
| US6528540 | BAXTER HLTHCARE | Esmolol formulation |
Jan, 2021
(3 years ago) | |
|
US6310094 (Pediatric) | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jul, 2021
(3 years ago) | |
|
US6528540 (Pediatric) | BAXTER HLTHCARE | Esmolol formulation |
Jul, 2021
(3 years ago) | |
Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 15 August, 1988
Treatment: NA
Dosage: INJECTABLE
How can I launch a generic of BREVIBLOC before it's drug patent expiration?
More Information on Dosage
BREVIBLOC family patents
2. Brevibloc Double Strength In Plastic Container patent expiration
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6310094 | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
| US6528540 | BAXTER HLTHCARE | Esmolol formulation |
Jan, 2021
(3 years ago) | |
|
US6310094 (Pediatric) | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jul, 2021
(3 years ago) | |
|
US6528540 (Pediatric) | BAXTER HLTHCARE | Esmolol formulation |
Jul, 2021
(3 years ago) | |
Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 15 August, 1988
Treatment: NA
Dosage: INJECTABLE
How can I launch a generic of BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER before it's drug patent expiration?
More Information on Dosage
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER family patents
3. Brevibloc In Plastic Container patent
expiration
BREVIBLOC IN PLASTIC CONTAINER IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6310094 | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
| US6528540 | BAXTER HLTHCARE | Esmolol formulation |
Jan, 2021
(3 years ago) | |
|
US6528540 (Pediatric) | BAXTER HLTHCARE | Esmolol formulation |
Jul, 2021
(3 years ago) | |
|
US6310094 (Pediatric) | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jul, 2021
(3 years ago) | |
Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 15 August, 1988
Treatment: NA
Dosage: INJECTABLE
How can I launch a generic of BREVIBLOC IN PLASTIC CONTAINER before it's drug patent expiration?
More Information on Dosage
BREVIBLOC IN PLASTIC CONTAINER family patents
4. Extraneal patent expiration
EXTRANEAL IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6077836 | BAXTER HLTHCARE | Peritoneal dialysis and compositions for use therein |
Jun, 2017
(7 years ago) | |
| US6248726 | BAXTER HLTHCARE | Method of peritoneal dialysis using glucose polymer solutions |
Jun, 2018
(6 years ago) | |
Drugs and Companies using ICODEXTRIN ingredient
Market Authorisation Date: 20 December, 2002
Treatment: Peritoneal dialysis solution
Dosage: SOLUTION
More Information on Dosage
EXTRANEAL family patents
5. Nexterone patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6869939 | BAXTER HLTHCARE | Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
May, 2022
(2 years ago) | |
| US7635773 | BAXTER HLTHCARE | Sulfoalkyl ether cyclodextrin compositions |
Mar, 2029
(4 years from now) | |
Drugs and Companies using AMIODARONE HYDROCHLORIDE ingredient
Market Authorisation Date: 24 December, 2008
Treatment: NA
Dosage: INJECTABLE
More Information on Dosage
NEXTERONE family patents
6. Suprane patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5617906 | BAXTER HLTHCARE | Container for anaesthetic agent |
Apr, 2014
(10 years ago) | |
|
US5617906 (Pediatric) | BAXTER HLTHCARE | Container for anaesthetic agent |
Oct, 2014
(9 years ago) | |
Drugs and Companies using DESFLURANE ingredient
Market Authorisation Date: 18 September, 1992
Treatment: NA
Dosage: LIQUID
How can I launch a generic of SUPRANE before it's drug patent expiration?
More Information on Dosage
SUPRANE family patents